US$ 28.37
generic glp-1 agonist Article » ProAct First Generic GLP-1 Injection OK'd
Description
This interaction is crucial for maintaining overall cardiovascular and renal health

Moreover, we recently demonstrated that activating GLP-1 receptor by exendin-4 treatment enhances the expression of NAMPT, SIRT1, and AMPK in mouse liver

[DOI] [PMC free article] [PubMed] [Google Scholar] 176.Turner R.C., Cull C.A., Frighi V., Holman R.R

Diabetes - GLP-1 agonists should be primarily considered in patients with type 2 diabetes with suboptimal glycaemic control despite maximal tolerated dose of metformin (+/- other agents) especially where weight loss is desired and/or significant stroke risk is present

GLP-1 increases ABCA1 mRNA and apo AI, mediating intracellular cholesterol efflux
